BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6628898)

  • 1. Single-cell origin of bladder cancer induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice with cellular mosaicism.
    Kakizoe T; Tanooka H; Tanaka K; Sugimura T
    Gan; 1983 Aug; 74(4):462-5. PubMed ID: 6628898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds.
    Hirose M; Fukushima S; Hananouchi M; Shirai T; Ogiso T
    Gan; 1976 Apr; 67(2):175-89. PubMed ID: 964550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC; Murphy WM; Daniel DS
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
    Pliss GB; Vlasov NN; Iogannsen MG; Frolov AG
    Vopr Onkol; 1998; 44(4):432-5. PubMed ID: 9807207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
    Tamano S; Shirai T; Kawabe M; Ni-I H; Mori Y; Okada M; Fukushima S
    Toxicol Pathol; 1992; 20(2):205-11. PubMed ID: 1475581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
    Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
    Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A technique for multiparametric analysis of hemodynamic changes in rat urinary bladder during carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Lurie AG; Rippey RM; Conran PB; Tatematsu M; Ito N
    Gan; 1979 Oct; 70(5):717-8. PubMed ID: 520763
    [No Abstract]   [Full Text] [Related]  

  • 8. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
    J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Fujita J; Yoshida O; Fujita H; Mikuni I
    Tokai J Exp Clin Med; 1983 Nov; 8(4):359-63. PubMed ID: 6679940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
    J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
    J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 15. Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide.
    Numoto S; Yoshida M; Otsuka H
    Gan; 1981 Oct; 72(5):647-54. PubMed ID: 7327366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
    J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B; Jeney A; Institoris L
    Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats].
    Komatsu H; Kakizoe T; Nishio Y; Honma Y; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2077-80. PubMed ID: 6677790
    [No Abstract]   [Full Text] [Related]  

  • 20. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.